Brii Biosciences Ltd - ESG Rating & Company Profile powered by AI
This ESG rating covers 17 UN Sustainable Development Goals including: 'Clean Water & Sanitation', 'Decent Work & Economic Growth' and 'Partnerships for the Goals'. This page is a zero-cost ESG assessment covering Brii Biosciences Ltd. Comprehensive ESG analysis of Brii Biosciences Ltd are accessed by logging in.
Brii Biosciences Ltd in the Biotechnology & Medical Research industry gained a UN SDG ESG Transparency Score of 3.3; made up of an environmental score of 4.0, social score of 4.6 and governance score of 1.3.
3.3
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Analytik Jena AG | 8.0 | High |
| 1 | Amniotics AB (publ) | 8.0 | High |
| ... | ... | ... | |
| 103 | Eurofins Scientific SE (Nantes Branch) | 3.4 | Medium |
| 103 | Titan Medical Inc | 3.4 | Medium |
| 105 | Brii Biosciences Ltd | 3.3 | Medium |
| 105 | Q linea AB | 3.3 | Medium |
| 107 | HAVN Life Sciences Inc | 3.1 | Medium |
| ... | ... | ... | |
| 182 | Wesana Health Holdings Inc | 0.0 | Low |
| 182 | rEVO Biologics Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Brii Biosciences Ltd have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Brii Biosciences Ltd disclose current and historical energy intensity?
Sign up for free to unlockDoes Brii Biosciences Ltd report the average age of the workforce?
Sign up for free to unlockDoes Brii Biosciences Ltd reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Brii Biosciences Ltd disclose its ethnicity pay gap?
Sign up for free to unlockDoes Brii Biosciences Ltd disclose cybersecurity risks?
Sign up for free to unlockDoes Brii Biosciences Ltd offer flexible work?
Sign up for free to unlockDoes Brii Biosciences Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Brii Biosciences Ltd disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Brii Biosciences Ltd conduct supply chain audits?
Sign up for free to unlockDoes Brii Biosciences Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Brii Biosciences Ltd conduct 360 degree staff reviews?
Sign up for free to unlockDoes Brii Biosciences Ltd disclose the individual responsible for D&I?
Sign up for free to unlockDoes Brii Biosciences Ltd disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Brii Biosciences Ltd disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Brii Biosciences Ltd disclose water use targets?
Sign up for free to unlockDoes Brii Biosciences Ltd have careers partnerships with academic institutions?
Sign up for free to unlockDid Brii Biosciences Ltd have a product recall in the last two years?
Sign up for free to unlockDoes Brii Biosciences Ltd disclose incidents of discrimination?
Sign up for free to unlockDoes Brii Biosciences Ltd allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Brii Biosciences Ltd issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Brii Biosciences Ltd disclose parental leave metrics?
Sign up for free to unlockDoes Brii Biosciences Ltd disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Brii Biosciences Ltd disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Brii Biosciences Ltd disclose the pay ratio of women to men?
Sign up for free to unlockDoes Brii Biosciences Ltd support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Brii Biosciences Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Brii Biosciences Ltd reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Brii Biosciences Ltd involved in embryonic stem cell research?
Sign up for free to unlockDoes Brii Biosciences Ltd disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Brii Biosciences Ltd disclose its waste policy?
Sign up for free to unlockDoes Brii Biosciences Ltd report according to TCFD requirements?
Sign up for free to unlockDoes Brii Biosciences Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Brii Biosciences Ltd disclose energy use targets?
Sign up for free to unlockDoes Brii Biosciences Ltd disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Brii Biosciences Ltd have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Brii Biosciences Ltd
These potential risks are based on the size, segment and geographies of the company.
Brii Biosciences Limited engages in the development of medicines for the treatment of infectious and central nervous system diseases. The company develops BRII-778 and BRII-732, which are in phase I clinical trials for the treatment of HIV patients; BRII-179 and BRII-835, which are in Phase 2 to evaluate the combination of these two HBV mechanisms for Hepatitis B; BRII-179, a recombinant protein-based HBV immunotherapeutic candidate that is in Phase 1b/2a; BRII-835, which has completed Phase-2 for patients with chronic HBV infection; and Amubarvimab/romlusevimab combination therapy for the treatment of COVID-19. It also develops BRII-296 for the treatment of PPD; BRII-297 for treatment of various depressive disorders; BRII-636, BRII-672, and BRII-693 for the treatment of multi-drug resistant/extensive drug resistant (MDR/XDR) gram-negative infections; and BRII-658 for the treatment of MDR/XDR tuberculosis and non-tuberculosis mycobacteria. The company was incorporated in 2017 and is based in Beijing, China.